Moderate to Severe Plaque Psoriasis Research (24 Weeks)

  • Adults aged 18 to 75 years (inclusive) with a diagnosis of plaque psoriasis for 24 weeks or more, may qualify for this study.
  • Qualified participants must also have moderate to severe disease with psoriatic plaques covering 10% or more body surface area. Individuals with a diagnosis of non-plaque psoriasis or drug-induced psoriasis, are not qualified for this study.
  • Participants will receive investigational oral medication (active study drug) or placebo. Study medication and study-related assessments will be provided at no cost. Reimbursement for study-related expenses may be provided.
  • Study participation will last about 24 weeks and involve about 9 visits to the study centre.

If interested, please contact our Research Coordinator  at 416-633-0001 x 4 or e-mail [email protected].

    Shopping Bag
    Your cart is emptyReturn to Shop
      Calculate Shipping
      Apply Coupon